Featured

Shanton Pharma's SAP-001 Receives FDA Fast Track Designation for Refractory Gout

Shanton Pharma announced that the FDA granted Fast Track designation to its investigational new drug, SAP-001, for treating hyperuricemia in adult gou...

Home/KnolSights/Regulatory Approvals/Shanton Pharma's SAP-001 Receives FDA Fast Track Designation for Refractory Gout